Niagen Bioscience (NAGE) Non-Current Deferred Tax Liability (2016 - 2018)

Niagen Bioscience (NAGE) has 3 years of Non-Current Deferred Tax Liability data on file, last reported at $19000.0 in Q4 2018.

• Non-Current Deferred Tax Liability for Q4 2018 came in at $19000.0, down 86.81% year-over-year; the trailing twelve-month figure through Dec 2018 was $19000.0 (down 86.81% YoY), and the FY2018 annual result was $19000.0, down 86.81% from the prior year.
• Non-Current Deferred Tax Liability retreated to $19000.0 in Q4 2018 per NAGE's latest filing, from $144000.0 in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $399000.0 in Q4 2016 and troughed at $19000.0 in Q4 2018.
• A 3-year average of $187333.3 and a median of $144000.0 in 2017 frame the typical range for Non-Current Deferred Tax Liability.
• The sharpest annual moves came in 2017 and 2018: Non-Current Deferred Tax Liability tumbled 63.91% in 2017, then plunged 86.81% in 2018.
• A 3-year view of Non-Current Deferred Tax Liability shows it stood at $399000.0 in 2016, then plunged by 63.91% to $144000.0 in 2017, then sank by 86.81% to $19000.0 in 2018.
• Business Quant data shows NAGE's Non-Current Deferred Tax Liability at $19000.0 in Q4 2018, $144000.0 in Q4 2017, and $399000.0 in Q4 2016.